Codenature Inc. (KOSDAQ:A078940) agreed to acquire 38.6% stake in Biogenicskorea Co., Ltd. from KOSSEN Co., Ltd. (KOSDAQ:A009730) for KRW 10.4 billion on July 25, 2022. The company will pay initial deposit of KRW 500 million and KRW 100 million on September 30, 2022 and remaining balance on closing date. The board of directors of Kossen has approved the transaction.

On December 30, 2022, KOSSEN Co., Ltd reported changes in transaction, Now KOSSEN will acquire 1,299,570 shares of Biogenicskore. The transaction is expected to close on December 30, 2022.